Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights
May 26 2017 - 6:59AM
Business Wire
Bristol-Myers Squibb Company (NYSE:BMY) will host a
teleconference on Sunday, June 4, 2017, at 6:30 p.m.
EDT (5:30 p.m. CDT) to discuss company strategy and review
data presented at the Annual Meeting of the American Society
of Clinical Oncology (ASCO) in Chicago. Company
executives will provide an overview of company strategy and data
presented at the meeting, with a focus on the company’s
immuno-oncology portfolio, and address inquiries from investors and
analysts.
Investors and the general public are invited to listen to a live
webcast of the call at investor.bms.com, by dialing toll free
(800) 236-0877 or international (719) 457-1036, confirmation code:
3209540. Materials related to the call will be available at the
same website prior to the call. A replay of the call will be
available beginning at 10:00 p.m. EDT on June 4
through 10:00 p.m. EDT on June 18. The replay can be
accessed at investor.bms.com or by dialing (888) 203-1112
or (719) 457-0820, confirmation code: 3209540.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us
at BMS.com or follow us on LinkedIn, Twitter,
YouTube and Facebook.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170526005046/en/
Bristol-Myers SquibbMedia:Ken Dominski,
609-252-5251ken.dominski@bms.comorInvestors:Ranya Dajani,
609-252-5330ranya.dajani@bms.comorBill Szablewski,
609-252-5894william.szablewski@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024